COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 439: Articles 4381-4390  | Next

Association of SARS-CoV-2 Nucleocapsid Protein Mutations with Patient Demographic and Clinical Characteristics during the Delta and Omicron Waves
Alsuwairi, F. A., Alsaleh, A. N., Alsanea, M. S., Al-Qahtani, A. A., Obeid, D., Almaghrabi, R. S., Alahideb, B. M., AlAbdulkareem, M. A., Mutabagani, M. S., Althawadi, S. I., Altamimi, S. A., Alshukairi, A. N., Alhamlan, F.
10.1101/2023.02.26.23285573 — Posted: 2023-03-01
Influence of COVID-19 on liver attenuation from two computed tomography scans over time: a retrospective study
Shumskaya, Y. F., Gonchar, A. P., Mnatsakanyan, M. G., Blokhin, I. A., Reshetnikov, R. V., Vasilev, Y. A.
10.1101/2023.02.27.23286488 — Posted: 2023-03-01
SARS-CoV-2 surveillance between 2020 and 2021 of all mammalian species in two Flemish zoos (Antwerp Zoo and Planckendael Zoo)
Joffrin, L., Cooreman, T., Verheyen, E., Vercammen, F., Marien, J., Leirs, H., Gryseels, S.
10.1101/2023.02.28.530444 — Posted: 2023-02-28
Rolosense: Mechanical detection of SARS-CoV-2 using a DNA-based motor
Piranej, S., Zhang, L., Bazrafshan, A., Marin, M., Melikyan, G. B., Salaita, K.
10.1101/2023.02.27.530294 — Posted: 2023-02-28
Engineered Immunogens to Expose Conserved Epitopes Targeted by Broad Coronavirus Antibodies
Kapingidza, B., Marston, D. J., Harris, C., Wrapp, D., Winters, K., Rhodes, B., Vure, P., Woods, C. W., Petzold, E. A., Walter, E. B., Parks, R., Barr, M., Yin, Q., Cain, D. W., Wiehe, K., Saunders, K. O., Haynes, B. F., Azoitei, M. L.
10.1101/2023.02.27.530277 — Posted: 2023-02-28
Neutralizing antibody levels and epidemiological information of patients with breakthrough COVID-19 infection in Toyama, Japan
Tani, H., Inasaki, N., Shimada, T., Saga, Y., Kaya, H., Maruyama, Y., Matano, S., Itoh, H., Kashii, T., Yamazaki, E., Yazawa, S., Itamochi, M., Oishi, K.
10.1101/2023.02.27.530346 — Posted: 2023-02-28
Coping with drug resistant tuberculosis alongside COVID-19 and other stressors in Zimbabwe: a qualitative study.
Timire, C., Kranzer, K., Pedrazzoli, D., Kavenga, F., Kasozi, S., Mbiba, F., Bond, V.
10.1101/2023.02.24.23286187 — Posted: 2023-02-27
Rapid resistance profiling of SARS-CoV-2 protease inhibitors
Moghadasi, S. A., Biswas, R., Harki, D. A., Harris, R.
10.1101/2023.02.25.530000 — Posted: 2023-02-27
Binding of SARS-CoV-2 non-structured protein 1 to 40S ribosome inhibits mRNA translation
Nguyen, H., Nguyen, L. H., Mai, L. S.
10.1101/2023.02.24.529933 — Posted: 2023-02-27
Cutaneous jet-injection of naked mRNA vaccine induces robust immune responses without systemic vaccine spillage
Abbasi, S., Matsui-Masai, M., Hayashi, A., Tockary, T., Akinaga, S., Kataoka, K., Uchida, S.
10.1101/2023.02.27.530188 — Posted: 2023-02-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).